TabsDetailsBasic DetailsDate: Friday, August 10, 2018Type: PublicationDescription: Stimulant abuse is associated with cardiomyopathy, but cardiomyopathy rates with therapeutic use of stimulants for attention-deficit/hyperactivity disorder (ADHD) are poorly characterized. Labels for methylphenidate, amphetamine, and atomoxetine caution against use in patients with cardiovascular disease. The authors sought to assess the incidence of new-onset heart failure or cardiomyopathy among initiators of these medications. Read More Materials: J Clin Psychopharmacol. 2018 Aug 10. doi: 10.1097/JCP.0000000000000939Additional InformationRelated Assessment(s): ADHD Medications and Heart FailureContributorsAuthor(s): Andrew D. Mosholder, Lockwood Taylor, Glenn Mannheim, Lisa Ortendahl, Tiffany S. Woodworth, Sengwee Toh